Analysis shows cluster dose impacts cell survival in ion therapy, highlighting the relevance of nanodosimetric quantities.
To demonstrate potential for a close association between cell survival and cluster dose for ionization parameters (Ip), and to investigate the means to quantify the degree of this association when calculating cluster dose using these nanodosimetric quantities. Approach: The definitions of Ip considered were the number of clusters of k or more ionizations per unit track length {Ck, k=1,…10}. For this definition, cluster dose is the number of clusters of k or more ionizations per unit mass. Three sets of published cell survival data, covering a range of clinically relevant particle types and energies, normal and tumor human cells, and aerobic and hypoxic conditions, were used to assess these Ip. Values of Ck were previously calculated for this survival data and evaluated for their application in treatment planning. New to this study, the dependence of cell survival on cluster dose, calculated as local fluence times the mean mass Ip, was used. The degree of association of cell survival with cluster dose was quantified using three statistical methods: the moving window method, the residuals of linear quadratic fit, and the Bayesian information criteria. Results: All three methods identified C5 as the most closely associated with cell survival under aerobic conditions, and C7 under hypoxic conditions. Remarkably, Ck preferred for their close association with cell survival for different particle types having the same fluence, compared to alternative definitions, resulted in a statistically significant closer association of cell survival with cluster dose, regardless of particle fluence. Significance: Cluster dose has the potential of supplementing or even replacing RBE-weighted dose in optimization of ion therapy treatment plans. The proposed methodology lays the groundwork for rigorous identification of Ip that exhibit the highest degree of association of cell survival with cluster dose, a trait that greatly enhances the potential clinical impact of cluster dose. .
No takes yet. Share an insight, caveat, or question.
Ortiz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: